Ariston, Irwin M.

HRN: 26-05-55  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/10/2025
06/17/2025
IV
600mg
Q8
Buerger’s Disease
Remove - Pending Acceptance
06/13/2025
CEFAZOLIN 1GM (VIAL)
06/13/2025
06/19/2025
IV
1gm
Q8
Buerger’s Disease
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: